We found that SLC7A9 expression levels were elevated in TP53-mutated gastric cancer, and further, that p53 can transcriptionally inhibit SLC7A9. Since both SLC7A11 and SLC7A9 are present in gastric cancer cells, it is necessary to reveal the relationship between these two proteins. The gene discussed is SLC7A11; the disease is gastric cancer.